title: A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer.
abstract: Stereotactic body radiation therapy (SBRT) is a new treatment modality. To confirm the safety and efficacy, the Radiation Therapy Study Group of the Japan Clinical Oncology Group (JCOG) has started a phase II study of SBRT for stage IA non-small cell lung cancer (JCOG 0403). This study is ongoing with a strict quality control and quality assurance program, and the results will indicate whether a future phase III trial comparing SBRT with surgery is warranted. In addition, international collaboration will be critical to establish the role of SBRT in the treatment of lung cancer.
authors.affiliation: Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho, Sakyo-ku, Kyoto, Japan. hiraok@kuhp.kyoto-u.ac.jp
authors.forename: Masahiro
authors.initials: M
authors.lastname: Hiraoka
authors.forename: Satoshi
authors.initials: S
authors.lastname: Ishikura
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D011786:Quality Control; D011829:Radiation Dosage; D016634:Radiosurgery / Q000592:standards